1. Home
  2. IGC vs KUKE Comparison

IGC vs KUKE Comparison

Compare IGC & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • KUKE
  • Stock Information
  • Founded
  • IGC 2005
  • KUKE 2002
  • Country
  • IGC United States
  • KUKE China
  • Employees
  • IGC N/A
  • KUKE N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • IGC Health Care
  • KUKE Real Estate
  • Exchange
  • IGC Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • IGC 39.8M
  • KUKE 42.0M
  • IPO Year
  • IGC N/A
  • KUKE 2021
  • Fundamental
  • Price
  • IGC $0.42
  • KUKE N/A
  • Analyst Decision
  • IGC Strong Buy
  • KUKE
  • Analyst Count
  • IGC 2
  • KUKE 0
  • Target Price
  • IGC $4.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • IGC 695.2K
  • KUKE 934.4K
  • Earning Date
  • IGC 11-11-2025
  • KUKE 10-21-2025
  • Dividend Yield
  • IGC N/A
  • KUKE N/A
  • EPS Growth
  • IGC N/A
  • KUKE N/A
  • EPS
  • IGC N/A
  • KUKE N/A
  • Revenue
  • IGC $1,327,000.00
  • KUKE $9,442,397.00
  • Revenue This Year
  • IGC $15.26
  • KUKE N/A
  • Revenue Next Year
  • IGC $3.41
  • KUKE N/A
  • P/E Ratio
  • IGC N/A
  • KUKE N/A
  • Revenue Growth
  • IGC 24.95
  • KUKE N/A
  • 52 Week Low
  • IGC $0.25
  • KUKE $0.52
  • 52 Week High
  • IGC $0.50
  • KUKE $10.00
  • Technical
  • Relative Strength Index (RSI)
  • IGC 52.73
  • KUKE 21.89
  • Support Level
  • IGC $0.39
  • KUKE $0.52
  • Resistance Level
  • IGC $0.43
  • KUKE $0.62
  • Average True Range (ATR)
  • IGC 0.02
  • KUKE 0.08
  • MACD
  • IGC -0.00
  • KUKE -0.03
  • Stochastic Oscillator
  • IGC 44.42
  • KUKE 9.01

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: